NCT03610685View on ClinicalTrials.gov

Inflammation Following Mepolizumab and Oral Corticosteroids in Asthma

PHASE4CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

October 19, 2018

Primary Completion Date

January 7, 2020

Study Completion Date

January 7, 2020

Conditions
Asthma
Interventions
DRUG

Prednisolone

Given daily for 2 weeks

DRUG

Placebo oral capsule

Given daily for 2 weeks

Trial Locations (1)

G12 0YN

Asthma and copd research centre, Glasgow

All Listed Sponsors
collaborator

Queen's University, Belfast

OTHER

lead

NHS Greater Glasgow and Clyde

OTHER

NCT03610685 - Inflammation Following Mepolizumab and Oral Corticosteroids in Asthma | Biotech Hunter | Biotech Hunter